Stem cell therapy: A new treatment for burns?

Pharmaceuticals

Volumn 4, Issue 10, 2011, Pages 1355-1380

  Arno, Anna ^a,b   Smith, Alexandra H ^a   Blit, Patrick H ^a   Al Shehab, Mohammed ^a   Gauglitz, Gerd G ^c   Jeschke, Marc G ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Burn; Regenerative medicine; Stem cells; Tissue engineering

Indexed keywords

ADIPOSE DERIVED STEM CELL; ADULT STEM CELL; ALLOGENEIC STEM CELL TRANSPLANTATION; BIOSAFETY; BONE MARROW CELL; BURN; CELL DENSITY; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; CELL TYPE; CELL VIABILITY; EMBRYONIC STEM CELL; HAIR FOLLICLE; HEMATOPOIETIC STEM CELL; HUMAN; INFECTION RISK; MESENCHYMAL STEM CELL; NONHUMAN; PATIENT SAFETY; PATIENT SATISFACTION; PHENOTYPIC PLASTICITY; PLURIPOTENT STEM CELL; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SKIN AUTOGRAFT; STEM CELL TRANSPLANTATION; THERAPY EFFECT; TISSUE REGENERATION; UMBILICAL CORD BLOOD; WOUND HEALING;

EID: 80055067230     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph4101355     Document Type: Review

References (164)

1. Atiyeh, B.; Costagliola, M. Cultured epithelial autograft (CEA) in burn treatment: Three decades later. Burns 2007, 33, 405-413.
2. Jones, I.; Currie, L.; Martin, R. A guide to biological skin substitutes. Br. J. Plast. Surg. 2002, 55, 185-193.
3. Zhang, C.P.; Fu, X.B. Therapeutic potential of stem cells in skin repair and regeneration. Chin. J. Traumatol. 2008, 11, 209-221.
4. Lataillade, J.J.; Doucet, C.; Bey, E.; Carsin, H.; Huet, C.; Clairand, I.; Bottollier-Depois, J.F.; Chapel, A.; Ernou, I.; Gourven, M. et al. New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy. Regen. Med. 2007, 2, 785-794.
5. Weil, B.R.; Markel, TA.; Herrmann, J.L.; Abarbanell, A.M.; Kelly, M.L.; Meldrum, D.R. Stem cells in sepsis. Ann. Surg. 2009, 250, 219-227.
6. Witkowska-Zimny, M.; Walenko, K. Stem cells from adipose tissue. Cell Mol. Biol. Lett. 2011, 16, 236-257.
7. Taylor, G.; Lehrer, M.S.; Jensen, P.J.; Sun, T.T.; Lavker, R.M. Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell 2000, 102, 451-461.
8. Ito, M.; Liu, Y.; Yang, Z.; Nguyen, J.; Liang, F.; Morris, R.J.; Cotsarelis, G. Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis. Nat. Med. 2005, 11, 1351-1354.
9. Lee, K.H. Tissue-engineered human living skin substitutes: Development and clinical application. Yonsei Med. J. 2000, 41, 774-779.
10. Leeb, C.; Jurga, M.; McGuckin, C.; Moriggl, R.; Kenner, L. Promising new sources for pluripotent stem cells. Stem Cell Rev. 2010, 6, 15-26.
11. Battey, J.F.; Cole, L.K. A stem cell primer. Pediatr. Res. 2006, 59, 1R-3R.
12. Branski, L.K.; Gauglitz, G.G.; Herndon, D.N.; Jeschke, M.G. A review of gene and stem cell therapy in cutaneous wound healing. Burns 2009, 35, 171-180.
13. Evans, M.J.; Kaufman, M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292, 154-156.
14. Thomson, J.A.; Itskovitz-Eldor, J.; Shapiro, S.S.; Waknitz, M.A.; Swiergiel, J.J.; Marshall, V.S.; Jones, J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282, 1145-1147.
15. Forraz, N.; McGuckin, C.P. The umbilical cord: a rich and ethical stem cell source to advance regenerative medicine. Cell Prolif. 2011, 44, 60-69.
16. Lin, G.; Xu, R.H. Progresses and challenges in optimization of human pluripotent stem cell culture. Curr. Stem Cell Res. Ther. 2010, 5, 207-214.
17. Parekkadan, B.; Milwid, J.M. Mesenchymal stem cells as therapeutics. Annu. Rev. Biomed. Eng. 2010, 12, 87-117.
18. Hadjantonakis, A.; Papaioannou, V. The stem cells of early embryos. Differentiation 2001, 68, 159-166.
19. Roh, C.; Lyle, S. Cutaneous stem cells and wound healing. Pediatr. Res. 2006, 59, 100R-103R.
20. Vats, A.; Tolley, N.S.; Polak, J.M.; Buttery, L.D. Stem cells: Sources and applications. Clin. Otolaryngol. Allied Sci. 2002, 27, 227-232.
21. Bishop, A.E.; Buttery, L.D.; Polak, J.M. Embryonic stem cells. J. Pathol. 2002, 197, 424-429.
22. Jiang, Y.; Jahagirdar, B.N.; Reinhardt, R.L.; Schwartz, R.E.; Keene, C.D.; Ortiz-Gonzalez, X.R.; Reyes, M.; Lenvik, T.; Lund, T.; Blackstad, M. et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418, 41-49.
23. Trounson, A. The production and directed differentiation of human embryonic stem cells. Endocr. Rev. 2006, 27, 208-219.
24. Amit, M.; Carpenter, M.K.; Inokuma, M.S.; Chiu, C.P.; Harris, C.P.; Waknitz, M.A.; Itskovitz-Eldor, J.; Thomson, J.A. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 2000, 227, 271-278.
25. Erdö, F.; Bührle, C.; Blunk, J.; Hoehn, M.; Xia, Y.; Fleischmann, B.; Föcking, M.; Küstermann, E.; Kolossov, E.; Hescheler, J. et al. Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke. J. Cereb. Blood Flow Metab. 2003, 23, 780-785.
26. Watt, F.M. Stem cell fate and patterning in mammalian epidermis. Curr. Opin. Genet. Dev. 2001, 11, 410-417.
27. Blau, H.M.; Brazelton, T.R.; Weimann, J.M. The evolving concept of a stem cell: Entity or function? Cell 2001, 105, 829-841.
28. Sartipy, P; Bjorquist, P; Strehl, R; Hyllner, J. The application of human embryonic stem cell technologies to drug discovery. Drug Discov. Today 2007, 12, 688-699.
29. Ende, M.; Ende, N. Hematopoietic transplantation by means of fetal (cord) blood. A new method. Va. Med. Mon. (1918) 1972, 99, 276-280.
30. Ziegner, U.H.; Ochs, H.D.; Schanen, C.; Feig, S.A.; Seyama, K.; Futatani, T.; Gross, T.; Wakim, M.; Roberts, R.L.; Rawlings, D.J. et al. Unrelated umbilical cord stem cell transplantation for X-linked immunodeficiencies. J. Pediatr. 2001, 138, 570-573.
31. Voltarelli, J.C.; Couri, C.E.; Stracieri, A.B.; Oliveira, M.C.; Moraes, D.A.; Pieroni, F.; Coutinho, M.; Malmegrim, K.C.; Foss-Freitas, M.C.; Simoes, B.P. et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2007, 297, 1568-1576.
32. Burt, R.K.; Traynor, A.; Statkute, L.; Barr, W.G.; Rosa, R.; Schroeder, J.; Verda, L.; Krosnjar, N.; Quigley, K.; Yaung, K. et al. Non-myeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 2006, 295, 527-535.
33. Zhou, Q; Brown, J; Kanarek, A; Rajagopal, J.; Melton, D.A. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 2008, 455, 627-632.
34. Burt, R.K.; Oyama, Y.; Verda, L.; Quigley, K.; Brush, M.; Yaung, K.; Statkute, L.; Traynor, A.; Barr, W.G. Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism. Arthritis Rheum. 2004, 50, 2466-2470.
35. Wang, W; Li, B; Yang, J; Xin, L.; Li, Y.; Yin, H.; Qi, Y.; Jiang, Y.; Ouyang, H.; Gao, C. The restoration of full-thickness cartilage defects with BMSCs and TGF-beta 1 loaded PLGA/fibrin gel constructs. Biomaterials 2010, 31, 8964-8973.
36. Undale, A.H.; Westendorf, J.J.; Yaszemski, M.J.; Khosla, S. Mesenchymal stem cells for bone repair and metabolic bone diseases. Mayo Clin. Proc. 2009, 84, 893-902.
37. Horwitz, E.M.; Gordon, P.L.; Koo, W.K.; Marx, J.C.; Neel, M.D.; McNall, R.Y.; Muul, L.; Hofmann, T. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc. Natl. Acad. Sci. USA 2002, 99, 8932-8937.
38. Blocklet, D.; Toungouz, M.; Berkenboom, G.; Lambermont, M.; Unger, P.; Preumont, N.; Stoupel, E.; Egrise, D.; Degaute, J.P.; Goldman, M. et al. Myocardial homing of nonmobilized peripheral-blood CD34+ cells after intracoronary injection. Stem Cells 2006, 24, 333-336.
39. Soldner, F.; Hockemeyer, D.; Beard, C.; Gao, Q.; Bell, G.W.; Cook, E.G.; Hargus, G.; Blak, A.; Cooper, O.; Mitalipova, M. et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009, 136, 964-977.
40. Rama, P.; Matuska, S.; Paganoni, G.; Spinelli, A.; de Luca, M.; Pellegrini, G. Limbal stem-cell therapy and long-term corneal regeneration. N. Engl. J. Med. 2010, 363, 147-155.
41. Badiavas, E.V.; Falanga, V. Treatment of chronic wounds with bone marrow-derived cells. Arch. Dermatol. 2003, 139, 510-516.
42. Gomillion, C.T.; Burg, K.J. Stem cells and adipose tissue engineering. Biomaterials 2006, 27, 6052-6063.
43. Herzog, E.L.; Chai, I.; Krause, D.S. Plasticity of marrow-derived stem cells. Blood 2003, 102, 3483-3493.
44. Hunt, D.P.; Morris, P.N.; Sterling, J.; Anderson, J.A.; Joannides, A.; Jahoda, C.; Compston, A.; Chandran, S. A highly enriched niche of precursor cells with neuronal and glial potential within the hair follicle dermal papilla of adult skin. Stem Cells 2008, 26, 163-172.
45. Jahoda, C.A.; Whitehouse, J.; Reynolds, A.J.; Hole, N. Hair follicle dermal cells differentiate into adipogenic and osteogenic lineages. Exp. Dermatol. 2003, 12, 849-859.
46. Gonzalez, F.; Boue, S.; Izpisua Belmonte, J.C. Methods for making induced pluripotent stem cells: Reprogramming a la carte. Nat. Rev. Genet. 2011, 12, 231-242.
47. Maherali, N.; Sridharan, R.; Xie, W.; Utikal, J.; Eminli, S.; Arnold, K.; Stadtfeld, M.; Yachechko, R.; Tchieu, J.; Jaenisch, R. et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 2007, 1, 55-70.
48. Wernig, M.; Meissner, A.; Foreman, R.; Brambrink, T.; Ku, M.; Hochedlinger, K.; Bernstein, B.E.; Jaenisch, R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007, 448, 318-324.
49. Zhou, Q.; Melton, D.A. Extreme makeover: Converting one cell into another. Cell Stem Cell 2008, 3, 382-388.
50. Cohen, D.E.; Melton, D. Turning straw into gold: Directing cell fate for regenerative medicine. Nat. Rev. Genet. 2011, 12, 243-252.
51. Vierbuchen, T.; Ostermeier, A.; Pang, Z.P.; Kokubu, Y.; Südhof, T.C.; Wernig, M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010, 463, 1035-1041.
52. Ieda, M.; Fu, J.D.; Delgado-Olquin, P.; Hayashi, Y.; Bruneau, B.G.; Srivastava, D. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010, 142, 375-386.
53. Szabo, E.; Rampalli, S.; Risueño, R.M.; Schnerch, A.; Mitchell, R.; Fiebig-Comyn, A.; Levadoux-Martin, M.; Bhatia, M. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 2010, 468, 521-526.
54. Feng, B.; Heng, J.C.; NQ, H.H. Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell 2009, 4, 301-312.
55. Takahashi, K; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126, 663-676.
56. Kimbrel, E.A.; Lu, S.J. Potential clinical applications for human pluripotent stem cell-derived blood components. Stem Cells Int. 2011, 2011, doi:10.4061/2011/273076.
57. Aasen, T.; Garreta, E.; Consiglio, A.; Gonzalez, F.; Vassena, R.; Bilic, J.; Pekarik, V.; Tiscornia, G.; Edel, M.; Boue, S. et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol. 2008, 26, 1276-1284.
58. Giorgetti, A.; Montserrat, N.; Aasen, T.; Gonzalez, F.; Rodriguez-Piza, I.; Vassena, R.; Raya, A.; Boue, S.; Barrero, M.J.; Corbella, B.A. et al. Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 2009, 5, 353-357.
59. Yu, J.; Vodyanic, M.A.; Smuga-Otto, K.; Antosiewicz-Bourget, J.; Frane, J.L.; Tian, S.; Nie, J.; Jonsdottir, G.A.; Ruotti, V.; Stewart, R. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318, 1917-1920.
60. Stadtfeld, M.; Brennand, K.; Hochedlinger, K. Reprogramming of pancreatic β cells into induced pluripotent stem cells. Curr. Biol. 2008, 18, 890-894.
61. Huang, G.T.; Gronthos, S.; Shi, S. Mesenchymal stem cells derived from dental tissues vs. those from other sources: Their biology and role in regenerative medicine. J. Dent. Res. 2009, 88, 792-806.
62. Uccelli, A.; Moretta, L.; Pistoia, V. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 2008, 8, 726-736.
63. Friedenstein, A.J.; Gorskaja, J.F.; Kulagina, N.N. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp. Hematol. 1976, 4, 267-274.
64. Zuk, P.A.; Zhu, M.; Ashjian, P.; de Ugarte, D.A.; Huang, J.I.; Mizuno, H.; Alfonso, Z.C.; Fraser, J.K.; Benhaim, P.; Hedrick, M.H. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 2002, 13, 4279-4295.
65. Fukuchi, Y.; Nakajima, H.; Sugiyama, D.; Hirose, I.; Kitamura, T.; Tsuji, K. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 2004, 22, 649-658.
66. Romanov, Y.A.; Svintsitskaya, V.A.; Smirnow, V.N. Searching for alternative sources of postnatal human mesenchymal stem cells: Candidate MSC-like cells from umbilical cord. Stem Cells 2003, 21, 105-110.
67. Gronthos, S; Mankani, M.; Brahim, J.; Robey, P.G.; Shi, S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc. Natl. Acad. Sci. USA 2000, 97, 13625-13630.
68. Bi, Y.; Ehirchiou, D.; Kilts, T.M.; Inkson, C.A.; Embree, M.C.; Sonoyama, W.; Li, L.; Leet, A.I.; Seo, B.M.; Zhang, L. et al. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat. Med. 2007, 13, 1219-1227.
69. Nöth, U.; Osyczka, A.M.; Tuli, R.; Hickok, N.J.; Danielson, K.G.; Tuan, R.S. Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J. Orthop. Res. 2002, 20, 1060-1069.
70. de Bari, C.; Dell'Accio, F.; Tylzanowski, P.; Luyten, F.P. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 2001, 44, 1928-1942.
71. Maumus, M.; Guerit, D.; Toupet, K.; Jorgensen, C.; Noël, D. Mesenchymal stem cell-based therapies in regenerative medicine: Applications in rheumatology. Stem Cell Res. Ther. 2011, 2, 14.
72. Bühring, H.J.; Battula, V.L.; Treml, S.; Schewe, B.; Kanz, L.; Vogel, W. Novel markers for the prospective isolation of human MSC. Ann. NY Acad. Sci. 2007, 1106, 262-271.
73. Fong, E.L.; Chan, C.K.; Goodman, S.B. Stem cell homing in musculoskeletal injury. Biomaterials 2011, 32, 395-409.
74. Tögel, F.; Cohen, A.; Zhang, P.; Yang, Y.; Hu, Z.; Westenfelder, C. Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. Stem Cells Dev. 2009, 18, 475-485.
75. Ghannam, S.; Bouffi, C.; Djouad, F.; Jorgensen, C.; Noël, D. Immunosuppression by mesenchymal stem cells: Mechanisms and clinical applications. Stem Cell Res. Ther. 2010, 1, 2.
76. Krampera, M.; Cosmi, L.; Angeli, R.; Pasini, A.; Liotta, F.; Andreini, A.; Santarlasci, V.; Mazzinghi, B.; Pizzolo, G.; Vinante, F. et al. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 2006, 24, 386-398.
77. Davis, D.R.; Stewart, D.J. Autologous cell therapy for cardiac repair. Expert Opin. Biol. Ther. 2011, 11, 489-508.
78. Aggarwal, S.; Pittenger, M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105, 1815-1822.
79. Meisel, R.; Zibert, A.; Laryea, M.; Göbel, U.; Däubener, W.; Dilloo, D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase mediated tryptophan degradation. Blood 2004, 103, 4619-4621.
80. Morandi, F.; Raffaghello, L.; Bianchi, G.; Meloni, F.; Salis, A.; Millo, E.; Ferrone, S.; Barnaba, V.; Pistoia, V. Immunogenicity of human mesenchymal stem cells in HLA-class-1-restricted T-cell responses against viral or tumor-associated antigens. Stem Cells 2008, 1275-1287.
81. Bartholomew, A.; Sturgeon, C.; Siatskas, M.; Ferrer, K.; McIntosh, K.; Patil, S.; Hardy, W.; Devine, S.; Ucker, D.; Deans, R. et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 2002, 30, 42-48.
82. Horwitz, E.M.; Prockop, D.J.; Fitzpatrick, L.A.; Koo, W.W.; Gordon, P.L.; Neel, M.; Sussman, M.; Orchard, P.; Marx, J.C.; Pyeritz, R.E. et al. Transplantability and therapeutic effects of bone marrow-derived msenchymal cells in children with osteogenesis imperfecta. Nat. Med. 1999, 5, 309-313.
83. Prockop, D.J.; Olson, S.D. Clinical trials with adult stem/progenitor cells for tissue repair. Let's not overlook some essential precautions. Blood 2007, 109, 3147-3151.
84. Frank, M.H.; Sayegh, M.H. Immunomodulatory functions of mesenchymal stem cells. Lancet 2004, 363, 1411-1412.
85. Le Blanc, K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 2003, 5, 485-489.
86. Kita, K.; Gauglitz, G.G.; Phan, T.T.; Herndon, D.N.; Jeschke, M.G. Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane. Stem Cells Dev. 2010, 19, 491-502.
87. Pittenger, M.F.; Mackay, A.M.; Beck, S.C.; Jaiswal, R.K.; Douglas, R.; Mosca, J.D.; Moorman, M.A.; Simonetti, D.W.; Craig, S.; Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284, 143-147.
88. Alvarez-Dolado, M.; Martinez-Losa, M. Cell fusion and tissue regeneration. Adv. Exp. Med. Biol. 2011, 713, 161-175.
89. Yamanaka, S.; Blau, H.M. Nuclear reprogramming of a pluripotent state by three approaches. Nature 2010, 465, 704-712.
90. Lluis, F.; Cosma, M.P. Cell-fusion-mediated somatic-cell reprogramming: A mechanism for tissue regeneration. J. Cell Physiol. 2010, 223, 6-13.
91. Wagner, J.E.; Gluckman, E. Umbilical cord blood transplantation: The first 20 years. Semin. Hematol. 2010, 47, 3-12.
92. Cha, J.; Falanga, V. Stem cells in cutaneous wound healing. Clin. Dermatol. 2007, 25, 73-78.
93. Falanga, V.; Iwamoto, S.; Chartier, M.; Yufit, T.; Butmarc, J.; Kouttab, N.; Shrayer, D.; Carson, P. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng. 2007, 13, 1299-1312.
94. Dawn, B.; Bolli, R. Adult bone marrow-derived stem cells: Regenerative potential, plasticity and tissue commitment. Basic Res. Cardiol. 2005, 100, 495-503.
95. Zuk, P.A.; Zhu, M.; Mizuno, H.; Huang, J.; Futrell, J.W.; Katz, A.J.; Benhaim, P.; Lorenz, H.P.; Hedrick, M.H. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng. 2001, 7, 211-218.
96. Rodda, D.J.; Chew, J.L.; Lim, L.H.; Loh, Y.H.; Wang, B.; Ng, H.H.; Robson, P. Transcriptional regulation of nanog by oct4 and sox2. J. Biol. Chem. 2005, 280, 24731-24737.
97. de Ugarte, D.A.; Alfonso, Z.; Zuk, P.A.; Elbarbary, A.; Zhu, M.; Ashjian, P.; Benhaim, P.; Hedrick, M.H.; Fraser, J.K. Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow. Immunol. Lett. 2003, 89, 267-270.
98. Prunet-Marcassus, B.; Cousin, B.; Caton, D.; Andre, M.; Penicaud, L.; Casteilla, L. From heterogeneity to plasticity in adipose tissues: Site-specific differences. Exp. Cell. Res. 2006, 312, 727-736.
99. Zuk, P.A. The adipose-derived stem cell: Looking back and looking ahead. Mol. Biol. Cell 2010, 21, 1783-1787.
100. Gimble, J.M.; Katz, A.J.; Bunnell, B.A. Adipose-derived stem cells for regenerative medicine. Circ. Res. 2007, 100, 1249-1260.
101. Wilson, A.; Butler, P.E.; Seifalian, A.M. Adipose-derived stem cells for clinical applications: A review. Cell Prolif. 2011, 44, 86-98.
102. Utsunomiya, T.; Shimada, M.; Imura, S.; Morine, Y.; Ikemoto, T.; Mori, H.; Hanaoka, J.; Iwahashi, S.; Saito, Y.; Iwaguro, H. Human adipose-derived stem cells: Potential clinical applications in surgery. Surg. Today 2011, 41, 18-23.
103. Ogawa, R. The importance of adipose-derived stem cells and vascularized tissue regeneration in the field of tissue transplantation. Curr. Stem Cell Res. Ther. 2006, 1, 13-20.
104. Sun, N; Panetta, N.J.; Gupta, D.M.; Wilson, K.D.; Lee, A.; Jia, F.; Hu, S.; Cherry, A.M.; Robbins, R.C.; Longaker, M.T. et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc. Natl. Acad. Sci. USA 2009, 106, 15720-15725.
105. Liu, H.; Chu, Y.; Lou, G. Fiber-modified adenovirus can mediate human adipose tissue-derived mesenchymal stem cell-based anti-angiogenic gene therapy. Biotechnol. Lett. 2010, 32, 1181-1188.
106. Tobita, M.; Orbay, H.; Mizuno, H. Adipose-derived stem cells: Current findings and future perspectives. Discov. Med. 2011, 11, 160-170.
107. Clinicaltrials. Available online: http://www.clinicaltrials.gov/ct2/results?term=adipose+derived+cells (Accessed on 5 June 2011).
108. Locke, M.; Feisst, V.; Dunbar, P.R. Concise review: Human adipose-derived stem cells: Separating promise from clinical need. Stem Cells 2011, 29, 404-411.
109. Yoshimura, K.; Sato, K.; Aoi, N.; Kurita, M.; Hirohi, T.; Harii, K. Cell-assisted lipotransfer for cosmetic breast augmentation: Supportive use of adipose-derived stem/stromal cells. Aesthetic Plast. Surg. 2008, 32, 48-55.
110. Bel, A.; Planat-Bernard, V.; Saito, A.; Bonnevie, L.; Bellamy, V.; Sabbah, L.; Bellabas, L.; Brinon, B.; Vanneaux, V.; Pradeau, P. et al. Composite cell sheets: A further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells. Circulation 2010, 122, S118-S123.
111. Casteilla, L.; Planat-Benard, V.; Laharrague, P.; Cousin, B. Adipose-derived stromal cells: Their identity and uses in clinical trials, an update. World J. Stem Cells 2011, 3, 25-33.
112. Knudtzon, S. In vitro growth of granulocytic colonies from circulating cells in human cord blood. Blood 1974, 43, 357-361.
113. Broxmeyer, H.E.; Douglas, G.W.; Hangoc, G.; Cooper, S.; Bard, J.; English, D.; Arny, M.; Thomas, L.; Boyse, E.A. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc. Natl. Acad. Sci. USA 1989, 86, 3828-3832.
114. McGuckin, C.P.; Pearce, D.; Forraz, N.; Tooze, J.A.; Watt, S.M.; Pettengell, R. Multiparametric analysis of immature cell populations in umbilical cord blood and bone marrow. Eur. J. Haematol. 2003, 71, 341-350.
115. McGuckin, C.; Forraz, N.; Baradez, M.O.; Basford, C.; Dickinson, A.M.; Navran, S.; Hartgerink, J.D. Embryonic-like stem cells from umbilical cord blood and potential for neural modeling. Acta Neurobiol. Exp. (Wars) 2006, 66, 321-329.
116. Denner, L.; Bodenburg, Y.; Zhao, J.G.; Howe, M.; Cappo, J.; Tilton, R.G.; Copland, J.A.; Forraz, N.; McGuckin, C.; Urban, R. Directed engineering of umbilical cord blood stem cells to produce C-peptide and insulin. Cell Prolif. 2007, 40, 367-380.
117. Sobolewski, K.; Malkowski, A.; Barikowski, E.; Jaworski, S. Wharton's jelly as a reservoir of peptide growth factors. Placenta 2005, 26, 747-752.
118. Majore, I.; Moretti, P.; Hass, R.; Kasper, C. Identification of subpopulations in mesenchymal stem cell-like cultures from human umbilical cord. Cell Commun. Signal. 2009, 7, 6.
119. Ishige, I.; Nagamura-Inoue, T.; Honda, M.J.; Harnprasopwat, R.; Kido, M.; Sugimoto, M.; Nakauchi, H.; Tojo, A. Comparison of mesenchymal stem cells derived from arterial, venous, and Wharton's jelly explants of human umbilical cord. Int. J. Hematol. 2009, 90, 261-269.
120. Wu, K.H.; Zhou, B.; Lu, S.H.; Feng, B.; Yang, S.G.; Du, W.T.; Gu, D.S.; Han, Z.C.; Liu, Y.L. In vitro and in vivo differentiation of human umbilical cord derived stem cells into endothelial cells. J. Cell Biochem. 2007, 100, 608-616.
121. Harris, D.T. Non-haematological uses of cord blood stem cells. Br. J. Haematol. 2009, 147, 177-184.
122. Zhao, Y.; Wang, H.; Mazzone, T. Identification of stem cells from human umbilical cord blood with embryonic and hematopoeitic characteristics. Exp. Cell Res. 2006, 312, 2454-2464.
123. Doan, P.L.; Chao, N.J. Advances in cord blood transplants in adults. F1000 Med. Rep. 2010, 2, 12.
124. Chunmeng, S.; Tianmin, C. Skin: A promising reservoir for adult stem cell populations. Med. Hypotheses 2004, 62, 683-688.
125. Amoh, Y.; Li, L.; Yang, M.; Moossa, A.R.; Katsuoka, K.; Penman, S.; Hoffman, R.M. Multipotent nestin-positive, keratin-negative hair follicle bulge stem cells can form neurons. Proc. Natl. Acad. Sci. USA 2005, 102, 5530-5534.
126. Amoh, Y.; Katsuoka, K.; Hoffman, R.M. The advantages of hair follicle pluripotent stem cells over embryonic stem cells and induced pluripotent stem cells for regenerative medicine. J. Dermatol. Sci. 2010, 60, 131-137.
127. Amoh, Y.; Kanoh, M.; Niyama, S.; Hamada, Y.; Kawahara, K.; Sato, Y.; Hoffman, R.M.; Katsuoka, K. Human hair follicle pluripotent stem (HFPS) cells promote regeneration of peripheral-nerve injury: An alternative to ES and iPS cells. J. Cell Biochem. 2009, 107, 1016-1020.
128. Oshima, H.; Rochat, A.; Kedzia, C.; Kobayashi, K.; Barrandon, Y. Morpohogenesis and renewal of hair follicles from adult multipotent stem cells. Cell 2001, 104, 233-245.
129. Langton, A.K.; Herrick, S.E.; Headon, D.J. An extended epidermal response heals cutaneous wounds in the absence of a hair follicle stem cell contribution. J. Invest. Dermatol. 2008, 128, 1311-1318.
130. Lengner, C.J. iPS cell technology in regenerative medicine. Ann. NY Acad. Sci. 2010, 1192, 38-44.
131. Wilmut, I.; Sullivan, G.; Chambers, I. The evolving biology of cell reprogramming. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2011, 366, 2183-2197.
132. Moustakas, A.; Heldin, C.H. The regulation of TGFβ signal transduction. Development 2009, 136, 3699-3714.
133. Rao, T.P.; Kühl, M. An update overview on Wnt signaling pathways: A prelude for more. Circ. Res. 2010, 106, 1798-1806.
134. Turner, N.; Grose, R. Fibroblast growth factor signalling: From development to cancer. Nat. Rev. Cancer 2010, 10, 116-129.
135. Ding, S.; Schultz, P.G. A role for chemistry in stem cell biology. Nat. Biotechnol. 2004, 22, 833-840.
136. Rubin, L.L. Stem cells and drug discovery: The beginning of a new era? Cell 2008, 132, 549-552.
137. Oldershaw, R.A.; Baxter, M.A.; Lowe, E.T.; Bates, N.; Grady, L.M.; Soncin, F.; Brison, D.R.; Hardingham, T.E.; Kimber, S.J. Directed differentiation of human embryonic stem cells toward chondrocytes. Nat. Biotechnol. 2010, 28, 1187-1194.
138. Chen, S.; Borowiak, M.; Fox, J.L.; Maehr, R.; Osafune, K.; Davidow, L.; Lam, K.; Peng, L.F.; Schreiber, S.L.; Rubin, L.L. et al. A small molecule that directs differentiation of human ESCs into the pancreatic lineage. Nat. Chem. Biol. 2009, 5, 258-265.
139. Leclerc, T.; Thepenier, P.J.; Bey, E.; Peltzer, J.; Trouillas, M.; Duhamel, P.; Bargues, L.; Prat, M.; Bonderriter, M.; Lataillade, J.J. Cell therapy of burns. Cell Prolif. 2011. 44, 48-54.
140. Butler, K.L.; Goverman, J.; Ma, H.; Fischman, A.; Yu, Y.M.; Bilodeau, M.; Rad, A.M.; Bonab, A.A.; Tompkins, R.G.; Fagan, S.P. Stem cells and burns: Review and therapeutic implications. J. Burn Care Res. 2010, 31, 874-881.
141. Dancey, D.R.; Hayes, J.; Gomez, M.; Schouten, D.; Fish, J.; Peters, W.; Slutsky, A.S.; Stewart, T.E. ARDS in patients with thermal injury. Intens. Care Med. 1999, 25, 1231-1236.
142. Khavari, P.A.; Rollman, O.; Vahlquist, A. Cutaneous gene transfer for skin and systemic diseases. J. Int. Med. 2002, 252, 1-10.
143. Sprugel, K.H.; McPherson, J.M.; Clowes, A.W.; Ross, R. Effects of growth factors in vivo. I. Cell ingrowth into porous subcutaneous chambers. Am. J. Pathol. 1987, 129, 601-613.
144. Drago, H.; Marin, G.H.; Sturla, F.; Roque, G.; Martire, K.; Diaz Aquino, V.; Lamonega, R.; Gardiner, C.; Ichim, T.; Riordan, N. et al. The next generation of burns treatment: Intelligent films and matrix, controlled enzymatic debridement, and adult stem cells. Transplant. Proc. 2010, 42, 345-349.
145. Mansilla, E.; Spretz, R.; Larsen, G.; Nuñez, L.; Drago, H.; Sturla, F.; Marin, G.H.; Roque, G.; Martire, K.; Diaz Aquino, V. et al. Outstanding survival and regeneration process by the use of intelligent acellular dermal matrices and mesenchymal stem cells in a burn pig model. Transplant. Proc. 2010, 42, 4275-4278.
146. Willmann, J.K.; Paulmurugan, R.; Rodriguez-Porcel, M.; Stein, W.; Brinton, T.J.; Connolly, A.J.; Nielsen, C.H.; Lutz, A.M.; Lyons, J.; Ikeno, F. et al. Imaging gene expression in human mesenchymal stem cells: From small to large animals. Radiology 2009, 252, 117-127.
147. Bannasch, H.; Unterberg, T.; Föhn, M.; Weyand, B.; Horch, R.E.; Stark, G.B. Burns: Cultured keratinocytes in fibrin with decellularised dermis close porcine full-thickness wounds in a single step. Burns 2008, 34, 1015-1021.
148. Kaufman, T.; Neuman, R.A.; Weinberg, A. Is postburn dermal ischaemia enhanced by oxygen free radicals? Burns 1989, 15, 291-294.
149. van der Veer, W.M.; Bloemen, M.C.; Ulrico, M.M.; Molema, G.; van Zuijlen, P.P.; Middelkoop, E.; Niessen, F.B. Potential cellular and molecular causes of hypertrophic scar formation. Burns 2009, 35, 15-29.
150. Chaby, G.; Senet, P.; Vaneau, M.; Martel, P.; Guillaume, J.C.; Meaume, S.; Teot, L.; Debure, C.; Dompmartin, A.; Bachelet, H. et al. Dressings for acute and chronic wounds: A systematic review. Arch. Dermatol. 2007, 143, 1297-1304.
151. Shinkai, M.; Ueda, K.; Ohtsu, S.; Honda, H.; Kohri, K.; Kobayashi, T. Effect of functional magnetic particles on radiofrequency capacitive heating: An in vivo study. Jpn. J. Cancer Res. 2002, 93, 103-108.
152. Mansilla, E.; Marin, G.H.; Drago, H.; Sturla, F.; Salas, E.; Gardiner, C.; Bossi, S.; Lamonega, R.; Guzman, A.; Nuñez, A. et al. Bloodstream cells phenotypically identical to human mesenchymal bone marrow stem cells circulate in large amounts under the influence of acute large skin damage: New evidence for their use in regenerative medicine. Transplant. Proc. 2006, 38, 967-969.
153. Nedeau, A.E.; Bauer, R.J.; Gallagher, K.; Chen, H.; Liu, Z.J.; Velazquez, O.C. A CXCL5- and bFGF-dependent effect of PDGF-B-activaded fibroblasts in promoting trafficking and differentiation of bone marrow-derived mesenchymal stem cells. Exp. Cell Res. 2008, 314, 2176-2186.
154. Fiorina, P.; Pietramaggiori, G.; Scherer, S.S.; Jurewicz, M.; Mathews, J.C.; Vergani, A.; Thomas, G.; Orsenigo, E.; Staudacher, C.; La Rosa, S. et al. The mobilization and effect of endogenous bone marrow progenitor cells in diabetic wound healing. Cell Transplant 2010, 19, 1369-1381.
155. Ha, X.; Yin, Q.; Dong, F.; Jia, Q.; Lv, T. Study on bone marrow mesenchymal stem cells transfected with adenovirus hepatocyte growth factor gene promoting wounds repair in diabetic rats. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2010, 24, 1520-1524.
156. Tark, K.C.; Hong, J.W.; Kim, Y.S.; Hahn, S.B.; Lee, W.J.; Lew, D.H. Effects of human cord blood mesenchymal stem cells on cutaneous wound healing in leprdb mice. Ann. Plast. Surg. 2010, 65, 565-572.
157. Advanced Cell Technology. Available online: http://www.advancedcell.com/potential-markets (Accessed on 10 August 2011).
158. Smith, D. Commercialization challenges associated with induced pluripotent stem cell-based products. Regen. Med. 2010, 5, 593-603.
159. Liras, A. Future research and therapeutic applications of human stem cells: General, regulatory, and bioethical aspects. J. Transl. Med. 2010, 8, 131-146.
160. FDA. Proposed Approach to Regulation of Cellular and Tissue-Based Products. Available online: http://www.fda.gov/downloads/BiologicasBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Tissue/UCM062601.pdf (Accessed on 26 July 2011).
161. Halme, D.G.; Kessler, D.A. FDA regulation of stem cell-based therapies. N. Engl. J. Med. 2006, 355, 1730-1735.
162. Metcalfe, A.D.; Ferguson, M.W. Tissue engineering of replacement skin: The crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration. J. R. Soc. Interface 2007, 4, 413-437.
163. Good manufacturing practices for pharmaceutical manufacturers. Available online: http://www.gmp-quality.com/index.html (Accessed on 8 September 2011).
164. The international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Available online: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6_R1/Step4/E6_R1__Guideline.pdf (Accessed on 15 August 2011).